Sort
51,570 grants matching “autoimmune disease”
STRATEGIES FOR TREATMENT AND PREVENTION OF DIABETES
$932,573University Of Pennsylvania · P01 · FY2000 · DK
STRATEGIES FOR TREATMENT AND PREVENTION OF DIABETES
$932,573University Of Pennsylvania · P01 · FY2002 · DK
STRATEGIES FOR TREATMENT AND PREVENTION OF DIABETES
$932,573University Of Pennsylvania · P01 · FY2004 · DK
STRATEGIES FOR TREATMENT AND PREVENTION OF DIABETES
$932,573University Of Pennsylvania · P01 · FY2001 · DK
Development of an inhibitory oligonucleotide for the treatment of lupus
$932,510Robert L Coffman · Dynavax Technologies Corporation · R44 · FY2009 · AI
Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells
$932,432Frances Eun-Hyung Lee · Emory University · R01 · FY2018 · AI
TISSUE INJURY AND INFLAMMATION IN MULTIPLE SCLEROSIS
$931,980Cleveland Clinic Foundation · P01 · FY2001 · NS
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice
$931,639Bruce Thomas Volpe · Feinstein Institute For Medical Research · P01 · FY2020 · AI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$931,259Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Lipid mediated oral tolerance
$931,012Sathy Venkat Balu-Iyer · State University Of New York At Buffalo · R01 · FY2025 · AI
Linking genome variation to transcriptional network dynamics in human B cells
$931,000Harinder Singh · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · HG
Linking genome variation to transcriptional network dynamics in human B cells
$931,000Harinder Singh · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · HG
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
$930,814Christopher P Larsen · Nephropathology Associates · R44 · FY2023 · DK
An allosteric inhibitor of ZAP-70 as a novel therapeutic for autoimmune disease
$930,793Arthur Weiss · University Of California, San Francisco · RC2 · FY2009 · AR
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
$930,427Wei-Jun Qian · Battelle Pacific Northwest Laboratories · U01 · FY2025 · DK
How Does blockade of CD40/CD40L Prevent Autoimmunity?
$930,029La Jolla Inst For Allergy &Immunolgy · U19 · FY2004 · AI
Epigenetic Regulation of T cell differentiation
$929,115Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Diabetes Evaluation in Washington (DEW-IT) Clinical Cen*
$929,041William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2006 · DK
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$928,753Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Pathophysiology of HTLV-I and HTLV-II Infection
$928,670Edward L Murphy · University Of California, San Francisco · R01 · FY2008 · HL
Mechanisms of varicella virus-induced multisystem disease using a primate model
$928,476Ravi Mahalingam · University Of Colorado Denver · P01 · FY2022 · AG
Structural and functional characterization of T and NK cell receptors
$928,309Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Regulatory T cells and the tumor microenvironment
$927,924Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2021 · CA
Epigenetic Regulation of T cell differentiation
$927,182Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$927,050Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR